Default company panoramic image

Teicos Pharma

Novel powder technology that allows virtually any pharmaceutical agent to be formulated as a highly efficient inhalable dry powder.

  • Stage Prototype Ready
  • Industry Nanotechnology
  • Location Helsinki, Uusimaa, Finland
  • Currency EUR
  • Founded October 2007
  • Employees 4
  • Website

Company Summary

Teicos' unique inhalation formulation technology allows high efficiency dosing & delivery of virtually any drug via the lung. This enables better dosing of existing drugs, dosing and delivery of new drugs not possible with existing technologies, extending expiring patent protection and better patient compliance that avoids side effects, discomfort and inconvenience of, e.g., injections or pills. Teicos licenses its technology to pharma companies.


  • 671415fc 85bd 4310 b03e 213a7022524e
    VP Business Development (Acting CEO)

    Dr. Brown is a serial entrepreneur (Teicos Pharma, Canatu, Particle Stream Technologies and StreamWise Finland), Fulbright Fellow, senior Research Scientist at AUSST, and engineering consultant to companies worldwide. He is a co-inventor of Teicos Pharma's technology. He has a PhD in Environmental Eng. and an M.S. in Aerospace Eng. and Eng. Mechanics from the University of Cincinnati and a B.S. in Aerospace Eng. from the University of Michigan.

  • Default avatar
    Janne Raula

    Dr. Raula is a senior research scientist at Aalto University School of Science and Technology (AUSST) and the co-inventor and key developer behind Teicos Pharma's technology. He is PhD in Chemistry. He has managed development and commercialization projects in drug formulation, inhalation device development and powder characterization for world leading drug, device and instrumentation companies.

  • Default avatar
    Jussi Pyysalo

    Mr. Pyysalo is a serial entrepreneur (BCB Medical Ltd, BC Brothers Finland Inc). Extensive experience from international marketing and proof of results.

  • Default avatar
    Taneli Jouhikainen
    Special Advisor

    A veteran executive in the medical and pharmaceutical industries (CEO at Akela Pharma, CEO at Focus Inhalation, chairman at Spectrum Medical Sciences etc.). He currently serves as Executive Vice President of Savara, Inc.,

  • Default avatar
    Esko Kauppinen
    Chief Scientist

    Professor at AUSST, leads the NanoMaterials Group at the Center for New Materials, Professor of Nanotechnology at the Technical Research Centre of Finland. Co-Inventor of Teicos technology.